Moolec Science SA MLEC
News
Trading Information
- Previous Close Price
- $1.40
- Day Range
- $0.80–1.54
- 52-Week Range
- $0.00–23.22
- Bid/Ask
- $0.24 / $0.38
- Shares Outstanding
- 725,565.00
- Market Cap
- $616,730.25
- Volume/Avg
- 273,279 / 42,115
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 150.18%
Company Profile
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 72
Valuation
Metric | MLEC |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.32 |
Price/Sales | 0.00 |
Price/Cash Flow | — |
Price/Earnings
MLEC
Financial Strength
Metric | MLEC |
|---|---|
Quick Ratio | 0.08 |
Current Ratio | 0.15 |
Interest Coverage | −2.96 |
Quick Ratio
MLEC
Profitability
Metric | MLEC |
|---|---|
Return on Assets (Normalized) | −123.65% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −113.93% |
Return on Assets
MLEC
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|f^%#t>! | LOCK|&^>< | $138B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|qvWBct | LOCK|N%z@ | $98B | |||
| Moderna Inc MRNA | LOCK|CwsXCnW | LOCK|ltv | $94B | |||
| argenx SE ADR ARGX | LOCK|h>!<z>& | LOCK|Gz | $62B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|$ywsk&q | LOCK|$#> | $50B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|jH!#$CXv | LOCK|<bcg$ | $31B | |||
| Incyte Corp INCY | LOCK|%!%@N&m | LOCK|PF | $25B | |||
| BioNTech SE ADR BNTX | LOCK|J<!m@C | LOCK|n&< | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|pHpK?KK | LOCK|<^!W | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|jwHpd?< | LOCK|hNQ | $15B |
United States